Sensor Medica’s participation in WHX Miami 2025 (Formerly FIME) ended with outstanding results, confirming once again the company’s central role in the global biomedical technology landscape. During the event – a benchmark for the healthcare sector in the Americas – our presence attracted the interest of specialised operators looking for advanced solutions for postural diagnostics and movement analysis.

 

With cutting-edge devices such as Spine3D, we presented an innovative approach to clinical assessment, capable of integrating technology, precision and ease of use. The attention received from the public testifies to the growing need for predictive and personalised tools, in line with our vision of increasingly future-oriented analysis.

 

WHX Miami 2025 was not only an important showcase for Italian manufacturing, but also a strategic step in the ongoing international expansion of Sensor Medica, which is now present in numerous markets and a reliable partner for those looking beyond the boundaries of traditional orthopaedics.

 

The project “International Expansion of Sensor Medica in the North American Market – WHX Miami 2025” has been carried out with the co-financing of the European Union through the European Regional Development Fund (ERDF), under the Lazio Regional Program ERDF 2021-2027, in accordance with the publicity obligations set out in Articles 49, 50 and Annex IX of Regulation (EU) 2021/1060 – CPR.

 

The goal of the project is to strengthen Sensor Medica’s presence in the North American market by expanding relationships with distributors, clinics, and hospitals, while promoting cutting-edge technologies for posture diagnostics and movement analysis, such as Freemed and Spine3D.

 

Thanks to the ERDF contribution, it has been possible to:

• Set up a customized exhibition booth aligned with the brand identity and expectations of the U.S. audience, ensuring a strong communication impact.

• Cover participation costs, including logistics, transport, and technical support during the event.

• Translate and adapt promotional and technical materials to the language and regulatory context of the U.S. market.

• Promote Sensor Medica’s technologies in a top-level international setting, facilitating connections with qualified healthcare operators and global decision-makers.

 

Participation in WHX Miami 2025 (Formerly FIME) marks a key milestone in Sensor Medica’s internationalization strategy, offering the opportunity to showcase the excellence of Made in Italy biomedical innovation to a highly selected audience and to open new commercial routes across North and South America.